Biomedical Engineering Reference
In-Depth Information
63. Ghosh, S., Ashcraft, K.: An IL-6 link between obesity and cancer. Front. Biosci. 5, 461-478
(2013)
64. Rose-John, S.: Coordination of interleukin-6 biology by membrane bound and soluble
receptors. Adv. Exp. Med. Biol. 495, 145-151 (2001)
65. Turkson, J., Jove, R.: STAT proteins: novel molecular targets for cancer drug discovery.
Oncogene 19, 6613-6626 (2000)
66. Mora, L.B., Buettner, R., et al.: Constitutive activation of Stat3 in human prostate tumors
and cell lines: direct inhibition of Stat3 signaling induces apoptosis of prostate cancer cells.
Cancer Res. 62, 6659-6666 (2002)
67. Abdulghani, J., Gu, L., et al.: Stat3 promotes metastatic progression of prostate cancer. Am.
J. Pathol. 172, 1717-1728 (2008)
68. Cawthorn, W.P., Sethi, J.K.: TNF-alpha and adipocyte biology. FEBS Lett. 582, 117-131
(2008)
69. Hillenbrand, A., Fassler, J., et al.: Changed adipocytokine concentrations in colorectal
tumor patients and morbidly obese patients compared to healthy controls. BMC Cancer 12,
545 (2012)
70. Raucci, R., Rusolo, F., et al.: Functional and structural features of adipokine family.
Cytokine 61, 1-14 (2013)
71. Jee, S.H., Chu, C.Y., et al.: Interleukin-6 induced basic fibroblast growth factor-dependent
angiogenesis
in
basal
cell
carcinoma
cell
line
via
JAK/STAT3
and
PI3-kinase/Akt
pathways. J. Invest. Dermatol. 123, 1169-1175 (2004)
72. Anzo, M., Cobb, L.J., et al.: Targeted deletion of hepatic Igf1 in TRAMP mice leads to
dramatic alterations in the circulating insulin-like growth factor axis but does not reduce
tumor progression. Cancer Res. 68, 3342-3349 (2008)
73. Bertolini, F., Lohsiriwat, V., et al.: Adipose tissue cells, lipotransfer and cancer: a challenge
for scientists, oncologists and surgeons. Biochim. Biophys. Acta 1826, 209-214 (2012)
74. van Kruijsdijk, R.C., van der Wall, E., et al.: Obesity and cancer: the role of dysfunctional
adipose tissue. Cancer Epidemiol. Biomark. Prev. 18, 2569-2578 (2009)
75. Hevener, A.L., Febbraio, M.A.: The 2009 stock conference report: inflammation, obesity
and metabolic disease. Obes. Rev. 11, 635-644 (2010)
76. Michigan, A., Johnson, T.V., et al.: Preoperative C-reactive protein level adjusted for
comorbidities
and
lifestyle
factors
predicts
overall
mortality
in
localized
renal
cell
carcinoma. Mol. Diagn. Ther. 15, 229-234 (2011)
77. Friedenreich, C.M., Langley, A.R., et al.: Case-control study of inflammatory markers and
the risk of endometrial cancer. Eur. J. Cancer Prev. 22, 374-379 (2013)
78. Bailey, A.S., Willenbring, H., et al.: Myeloid lineage progenitors give rise to vascular
endothelium. Proc. Natl. Acad. Sci. U.S.A. 103, 13156-13161 (2006)
79. Weisberg, S.P., McCann, D., et al.: Obesity is associated with macrophage accumulation in
adipose tissue. J. Clin. Invest. 112, 1796-1808 (2003)
80. Arendt, L.M., McCready, J., et al.: Obesity promotes breast cancer by CCL2-mediated
macrophage recruitment and angiogenesis. Cancer Res. 73, 6080-6093 (2013)
81. Jones, B.J., McTaggart, S.J.: Immunosuppression by mesenchymal stromal cells: from
culture to clinic. Exp. Hematol. 36, 733-741 (2008)
82. Fidler, I.J., Ellis, L.M.: The implications of angiogenesis for the biology and therapy of
cancer metastasis. Cell 79, 185-188 (1994)
83. Cao, Y.: Adipose tissue angiogenesis as a therapeutic target for obesity and metabolic
diseases. Nat. Rev. Drug Discovery 9, 107-115 (2010)
84. Vona-Davis, L., Rose, D.P.: Adipokines as endocrine, paracrine, and autocrine factors in
breast cancer risk and progression. Endocr. Relat. Cancer 14, 189-206 (2007)
85. Resi, V., Basu, S., et al.: Molecular inflammation and adipose tissue matrix remodeling
precede physiological adaptations to pregnancy. Am. J. Physiol. Endocrinol. Metab. 303,
E832-E840 (2012)
86. Delort, L., Lequeux, C., et al.: Reciprocal interactions between breast tumor and its adipose
microenvironment based on a 3D adipose equivalent model. PLoS ONE 8, e66284 (2013)
Search WWH ::
Custom Search